FR2378768B1 - - Google Patents

Info

Publication number
FR2378768B1
FR2378768B1 FR7803369A FR7803369A FR2378768B1 FR 2378768 B1 FR2378768 B1 FR 2378768B1 FR 7803369 A FR7803369 A FR 7803369A FR 7803369 A FR7803369 A FR 7803369A FR 2378768 B1 FR2378768 B1 FR 2378768B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7803369A
Other versions
FR2378768A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Priority claimed from DE19782811849 external-priority patent/DE2811849A1/de
Publication of FR2378768A1 publication Critical patent/FR2378768A1/fr
Application granted granted Critical
Publication of FR2378768B1 publication Critical patent/FR2378768B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/08—Aza-anthracenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7803369A 1976-09-22 1978-02-07 2,6-methano-3-benzazocines et leur utilisation comme medicaments Granted FR2378768A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72537176A 1976-09-22 1976-09-22
US78574677A 1977-04-08 1977-04-08
US05/818,713 US4119628A (en) 1976-09-22 1977-07-25 Process for preparing hexahydro-11 (eq)-CH2 CH2 COR5 -2,6-methano-3-benzazocines
DE19782811849 DE2811849A1 (de) 1976-09-22 1978-03-17 2,6-methano-3-benzazocine, verfahren zu deren herstellung und arzneimittel

Publications (2)

Publication Number Publication Date
FR2378768A1 FR2378768A1 (fr) 1978-08-25
FR2378768B1 true FR2378768B1 (fr) 1981-05-29

Family

ID=27432292

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7728584A Granted FR2375216A1 (fr) 1976-09-22 1977-09-22 2,5-methanobenzo (g) quinoleine-3-carboxylates (esters)
FR7803369A Granted FR2378768A1 (fr) 1976-09-22 1978-02-07 2,6-methano-3-benzazocines et leur utilisation comme medicaments

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7728584A Granted FR2375216A1 (fr) 1976-09-22 1977-09-22 2,5-methanobenzo (g) quinoleine-3-carboxylates (esters)

Country Status (10)

Country Link
US (2) US4119628A (fr)
JP (1) JPS5340777A (fr)
BE (1) BE858866A (fr)
CA (1) CA1095905A (fr)
CH (2) CH626882A5 (fr)
DE (1) DE2742715A1 (fr)
FR (2) FR2375216A1 (fr)
GB (1) GB1551562A (fr)
LU (1) LU78162A1 (fr)
NL (1) NL187630C (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255579A (en) * 1974-05-20 1981-03-10 Sterling Drug Inc. 11-Substituted hexahydro-2,6-methano-3-benzazocines
BE864950A (fr) * 1976-09-22 1978-09-18 Sterling Drug Inc 2,6-methano-3-benzazocines
EP0019056A1 (fr) * 1979-03-26 1980-11-26 Sterling Drug Inc. Procédé de préparation de 11-alkoxy inférieur et alkylthio inférieur 3-oxo alkyl inférieur-hexahydro-2,6-méthane-3-benzazocines
US4912114A (en) * 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives
JP6400592B2 (ja) * 2012-11-09 2018-10-03 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932422A (en) * 1974-05-20 1976-01-13 Sterling Drug Inc. 8-Methylene-3-azabicyclo[3.3.1]non-6-en-4-ones

Also Published As

Publication number Publication date
FR2378768A1 (fr) 1978-08-25
DE2742715A1 (de) 1978-03-23
CA1095905A (fr) 1981-02-17
JPS6224424B2 (fr) 1987-05-28
NL187630C (nl) 1991-12-02
US4148794A (en) 1979-04-10
NL187630B (nl) 1991-07-01
GB1551562A (en) 1979-08-30
FR2375216A1 (fr) 1978-07-21
AU2903077A (en) 1979-03-29
BE858866A (fr) 1978-03-20
LU78162A1 (fr) 1978-06-01
FR2375216B1 (fr) 1980-09-19
JPS5340777A (en) 1978-04-13
NL7710325A (nl) 1978-03-28
CH624939A5 (fr) 1981-08-31
US4119628A (en) 1978-10-10
CH626882A5 (fr) 1981-12-15

Similar Documents

Publication Publication Date Title
FR2356961B1 (fr)
FR2378768B1 (fr)
JPS5759003B2 (fr)
FR2378782B1 (fr)
JPS5327684B2 (fr)
JPS5315264U (fr)
JPS52124090U (fr)
JPS5523695Y2 (fr)
JPS5433858Y2 (fr)
JPS5388773U (fr)
JPS5366585U (fr)
JPS5320744U (fr)
CH598628A5 (fr)
DD125436A1 (fr)
BG23137A1 (fr)
CH597561A5 (fr)
DD124316A1 (fr)
DD127055A1 (fr)
DD126738A1 (fr)
BG23223A1 (fr)
DD126717A1 (fr)
DD126631A1 (fr)
DD126582A1 (fr)
DD126483A1 (fr)
BG23383A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse